Sustainable Solutions For Medical Devices: Lower Scope 3 Emissions With Ulteeva Purity™ Bio-Based UHMWPE

Medical device companies face the dual challenge of ensuring patient safety while addressing environmental sustainability. With healthcare responsible for 4.8-5.2% of global greenhouse gas emissions, reducing Scope 3 emissions—such as those from purchased goods and services—has become essential. dsm-firmenich addresses this need with bio-based Ultra High Molecular Weight Polyethylene (UHMWPE), including Ulteeva Purity™ powder and fiber, used in devices like orthopedic sutures, catheters, and artificial joints.

Bio-based UHMWPE is derived from renewable naphtha, a byproduct of wood pulp. Through processes such as cracking and polymerization, bio-based naphtha is converted into ethylene and subsequently UHMWPE. Certified as bio-based by the International Sustainability & Carbon Certification (ISCC), this material is chemically identical to fossil-based UHMWPE, ensuring no changes to quality, reliability, or clinical benefits.

Ulteeva Purity™ products are produced using 100% renewable electricity, reducing carbon footprints by up to 70% compared to traditional UHMWPE. This makes them nearly carbon neutral while maintaining the trusted performance and clinical history of the former Dyneema Purity® fiber.

As sustainability becomes a consumer and industry priority, dsm-firmenich leads with innovative, eco-conscious biomaterials, helping medical device companies reduce their environmental impact. This aligns with dsm-firmenich's mission of combining science, sustainability, and innovation to enhance healthcare solutions.